Matrixyl (Palmitoyl Pentapeptide) vs PT-141 (Bremelanotide)

A side-by-side comparison from PeptideSciences101, the open peptide reference.

Overview

Matrixyl (Palmitoyl Pentapeptide) and PT-141 (Bremelanotide) are both cosmetic & skin peptides, but they differ in mechanism, dosing, and regulatory status.

This page compares Matrixyl (Palmitoyl Pentapeptide) and PT-141 (Bremelanotide) across their primary use, typical dosing, reported benefits and side effects, and U.S. regulatory status. For the full monograph on either compound — mechanism of action, clinical research, and references — follow the article links.

Side-by-side comparison

Matrixyl (Palmitoyl Pentapeptide)PT-141 (Bremelanotide)
CategoryCosmetic & SkinCosmetic & Skin
Regulatory status (US)Research use onlyResearch use only
Typical dosageTopical application1.75 mg
Frequencydailyas needed
Reported benefitsWrinkle reduction, skin firmness, collagen stimulation, improved skin textureEnhanced libido, sexual function
Reported side effectsVery safe for topical use. Rare: mild irritationNausea, flushing, blood pressure changes

Key differences

Primary use. Matrixyl (Palmitoyl Pentapeptide) is categorised under Cosmetic & Skin, while PT-141 (Bremelanotide) falls under Cosmetic & Skin. Because they target a similar goal, they are common alternatives to weigh against each other.

Regulatory status. Matrixyl (Palmitoyl Pentapeptide): not FDA-approved; treated as a research compound. PT-141 (Bremelanotide): not FDA-approved; treated as a research compound.

Dosing. Matrixyl (Palmitoyl Pentapeptide) is typically dosed at Topical application (daily). PT-141 (Bremelanotide) is typically dosed at 1.75 mg (as needed).

Can you stack them?

Some protocols combine peptides, but stacking Matrixyl (Palmitoyl Pentapeptide) and PT-141 (Bremelanotide) has not been validated for safety or efficacy in controlled trials. Combining compounds can change their effects and risks. Nothing here is medical advice — consult a qualified healthcare provider before starting or combining any protocol.

Frequently asked questions

What is the difference between Matrixyl (Palmitoyl Pentapeptide) and PT-141 (Bremelanotide)?
Matrixyl (Palmitoyl Pentapeptide) and PT-141 (Bremelanotide) are both cosmetic & skin peptides, but they differ in mechanism, dosing, and regulatory status. Matrixyl (Palmitoyl Pentapeptide) is not FDA-approved; generally classified as a research compound, whereas PT-141 (Bremelanotide) is not FDA-approved; generally classified as a research compound.
What is Matrixyl (Palmitoyl Pentapeptide) used for?
Anti-aging skincare.
What is PT-141 (Bremelanotide) used for?
Libido enhancement peptide.
Can you take Matrixyl (Palmitoyl Pentapeptide) and PT-141 (Bremelanotide) together?
Some users combine peptides within a single protocol, but stacking Matrixyl (Palmitoyl Pentapeptide) and PT-141 (Bremelanotide) has not been established as safe or effective in controlled trials. Neither this comparison nor PeptideSciences101 is medical advice — consult a qualified healthcare provider before combining any compounds.
Is Matrixyl (Palmitoyl Pentapeptide) or PT-141 (Bremelanotide) FDA-approved?
Matrixyl (Palmitoyl Pentapeptide) is not FDA-approved; generally classified as a research compound. PT-141 (Bremelanotide) is not FDA-approved; generally classified as a research compound.

Read the full articles

More Cosmetic & Skin comparisons

← All peptide comparisons